SCHEMBL21670802

SCHEMBL21670802

CCc1nc([C@H](Cc2cccc(N)c2)NC(=O)C(Cc2ccccc2)NC(=O)OC)cs1

nearest known ligand 0.71

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PTPRB P23467 20/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL684270 0.92 PTPRB (0.77) PTPRB
SCHEMBL679064 0.92 PTPRB (0.77) PTPRB
SCHEMBL468199 0.92 PTPRB (0.77) PTPRB
SCHEMBL24534137 0.92 PTPRB (0.77) PTPRB
SCHEMBL24534156 0.87 PTPRB (0.78) PTPRB
SCHEMBL24527309 0.87 PTPRB (0.78) PTPRB
SCHEMBL18349258 0.86 PTPRB (0.81) PTPRB
SCHEMBL24534187 0.86 PTPRB (0.75) PTPRB
SCHEMBL27920739 0.84 PTPRB (0.75) PTPRB
SCHEMBL27920744 0.84 PTPRB (0.75) PTPRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3607821-A1 COMPOSITIONS, FORMULATIONS AND METHODS FOR TREATING OCULAR DISEASES Aerpio Therapeutics, Inc. (US) 2020-02-12 EP disclosed